| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_998dc4a1166c7aa53aee95ac4a88ab9a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b1aeb07b4f90f7ba3e3c217a5f5b1ef |
| publicationDate |
2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018271808-A1 |
| titleOfInvention |
Methods of reducing chemoresistance and treating cancer |
| abstract |
Methods of treating cancer include administering a therapeutically effective amount of a pharmaceutical composition containing a pharmaceutically acceptable carrier and a compound that is a GPR55 antagonist to a subject having a tumor including cancer cells that have developed a resistance to one or more chemotherapeutic agents. In embodiments, the compound is a fenoterol analogue, such as for example, MNF. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10610280-B1 |
| priorityDate |
2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |